- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SynCore Biotechnology Co Ltd (4192)
SynCore Biotechnology Co Ltd stock price live, this page displays TWO 4192 stock exchange data. View the 4192 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SynCore Biotechnology Co Ltd real time stock price chart below.
What Is the SynCore Biotechnology Co Ltd Stock Price Today?
The SynCore Biotechnology Co Ltd stock price today is 18.75.
What Is the Stock Symbol for SynCore Biotechnology Co Ltd?
The stock symbol for SynCore Biotechnology Co Ltd is "4192."
What Stock Exchange Does SynCore Biotechnology Co Ltd Trade On?
SynCore Biotechnology Co Ltd is listed and trades on the TPEX stock exchange.
Is SynCore Biotechnology Co Ltd a Good Stock to Buy?
Determining whether SynCore Biotechnology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4192 quote. (ISIN: TW0004192000)
What Is the SynCore Biotechnology Co Ltd Stock Price Today?
The SynCore Biotechnology Co Ltd stock price today is 18.75.
What Is the Stock Symbol for SynCore Biotechnology Co Ltd?
The stock symbol for SynCore Biotechnology Co Ltd is "4192."
What Stock Exchange Does SynCore Biotechnology Co Ltd Trade On?
SynCore Biotechnology Co Ltd is listed and trades on the TPEX stock exchange.
Is SynCore Biotechnology Co Ltd a Good Stock to Buy?
Determining whether SynCore Biotechnology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4192 quote. (ISIN: TW0004192000)
TPEX
Currency in TWD
18.75
-0.10(-0.53%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.75
18.80
52 wk Range
18.05
29.65
4192 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.7518.80
52 wk Range
18.0529.65
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4192 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
May 14, 2026
EPS / Forecast
-0.37 / --
Revenue / Forecast
6.12M / --
Compare 4192 to Peers and Sector
Metrics to compare | 4192 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4192PeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.6x | −6.0x | −0.4x | |
PEG Ratio | - | 0.06 | 0.00 | |
Price/Book | 2.8x | 2.4x | 2.6x | |
Price / LTM Sales | 23.7x | 7.2x | 3.1x | |
Upside (Analyst Target) | - | 0.0% | 47.8% | |
Fair Value Upside | Unlock | −3.8% | 6.2% | Unlock |
SynCore Biotechnology Co.,Ltd, engages in development and sale of healthy food, medicine inspection, and biotechnology service in Taiwan. The company is involved in the development of SB01, an injectable anti-cancer new ingredient (NCE) that is in Phase II clinical trials for the treatment of head and neck cancer; and SB02, an anti-cancer NCE, which is in preclinical research for use in the treatment of stomach cancer. It also offers SB03-Veregen, an ointment for the treatment of patients with external genital and perianal warts EGW; and SB04, a conventional drug for the treatment of age-related macular degeneration dry AMD that is in Phase II/III clinical trials. In addition, the company provides SB05-EndoTAG-1, a conventional drug for pancreatic cancer and triple-negative breast cancer that is in Phase III clinical trials. Further, it distributes cameras under the epiCam name such as hand-held color, hand-held monochrome, and veterinary fundus cameras that is used in recording the progress of ophthalmology diseases; and choroidal blood flow measurement. The company has partnerships with Aresus, MacuCLEAR Inc.; Y-YBAR; Epipole; and Sinphar Pharmaceutical Co., Ltd.; and The National Health Research Institutes NHRI. The company was incorporated in 2008 and is headquartered in Yilan City, Taiwan. SynCore Biotechnology Co.,Ltd operates as a subsidiary of Sinphar Pharmaceutical Co., Ltd.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the SynCore BioTech (4192) Stock Price Today?
The SynCore BioTech stock price today is 18.75 TWD.
What Stock Exchange Does SynCore BioTech Trade On?
SynCore BioTech is listed and trades on the Taipei Exchange.
What Is the Stock Symbol for SynCore BioTech?
The stock symbol for SynCore BioTech is "4192."
What Is the SynCore BioTech Market Cap?
As of today, SynCore BioTech market cap is 659.33M TWD.
What Is SynCore BioTech's Earnings Per Share (TTM)?
The SynCore BioTech EPS (TTM) is -1.28.
From a Technical Analysis Perspective, Is 4192 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has SynCore BioTech Stock Split?
SynCore BioTech has split 2 times.
How Many Employees Does SynCore BioTech Have?
SynCore BioTech has 40 employees.
What is the current trading status of SynCore BioTech (4192)?
As of Aug 16, 2026, SynCore BioTech (4192) is trading at a price of 18.75 TWD, with a previous close of 32.80 TWD. The stock has fluctuated within a day range of 18.75 TWD to 18.80 TWD, while its 52-week range spans from 18.05 TWD to 29.65 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.